Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Alzheimers Dis ; 74(3): 951-964, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32116255

RESUMO

Alzheimer's disease (AD) is the most frequent neurodegenerative disorder, affecting over 44 million people worldwide. There are no effective pharmaco-therapeutic options for prevention and treatment of AD. Non-pharmacological approaches may help patients suffering from AD to significantly ameliorate disease progression. In this study, we exposed a transgenic rat model (tg) of human tauopathy to enriched environment for 3 months. Behavioral testing at 6 months of age revealed improvement in functional deficits of tg rats reared under enriched conditions, while sedentary tg rats remained severely impaired. Interestingly, enriched environment did not reduce tau pathology. Analysis of neurotrophic factors revealed an increase of nerve growth factor (NGF) levels in the hippocampus of both enriched groups (tg and non-tg rats), reflecting a known effect of enriched environment on the hippocampal formation. On the contrary, NGF levels decreased markedly in the brainstem of enriched groups. The non-pharmacological treatment also reduced levels of tissue inhibitor of metalloproteinase 1 in the brainstem of transgenic rats. Expression analysis of inflammatory pathways revealed upregulation of microglial markers, such as MHC class II and Cd74, whereas levels of pro-inflammatory cytokines remained unaffected by enriched environment. Our results demonstrate that exposure to enriched environment can rescue functional impairment in tau transgenic rats without reducing tau pathology. We speculate that non-pharmacological treatment modulates the immune response to pathological tau protein inclusions, and thus reduces the damage caused by neuroinflammation.


Assuntos
Transtornos Cognitivos/prevenção & controle , Encefalite/prevenção & controle , Meio Ambiente , Tauopatias/psicologia , Tauopatias/reabilitação , Animais , Transtornos Cognitivos/psicologia , Citocinas/metabolismo , Encefalite/psicologia , Humanos , Masculino , Fator de Crescimento Neural/metabolismo , Fosforilação , Ratos , Ratos Endogâmicos SHR , Ratos Transgênicos , Receptores CCR2/metabolismo , Inibidor Tecidual de Metaloproteinase-1/metabolismo , Proteínas tau/genética , Proteínas tau/metabolismo
2.
Neurocase ; 24(3): 156-160, 2018 06.
Artigo em Inglês | MEDLINE | ID: mdl-30015554

RESUMO

Corticobasal degeneration (CBD) is a neurodegenerative disorder characterized by a combination of cortical and basal ganglia signs. We reported two cases treated with a bilateral upper limb rehabilitation tool with videogame based feedback for 3 time per week for 8 weeks. Both patients showed an improvement of pinch and grasp forces and motor function. However, both of them reported an increased upper limb pain. Bilateral upper limb mechanical device with exergame feedback was effective also in the two patients suffering of CBD for limiting the effects of apraxia by performing intensive purposeful task training.


Assuntos
Apraxias/reabilitação , Retroalimentação Psicológica , Reabilitação Neurológica/métodos , Transtornos Parkinsonianos/reabilitação , Tauopatias/reabilitação , Extremidade Superior/fisiopatologia , Jogos de Vídeo , Idoso , Apraxias/etiologia , Feminino , Humanos , Reabilitação Neurológica/instrumentação , Transtornos Parkinsonianos/complicações , Tauopatias/complicações
3.
Neurobiol Dis ; 71: 180-92, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25132556

RESUMO

The number of patients with Alzheimer's disease (AD) is increasing worldwide, and available drugs have shown limited efficacy. Hence, preventive interventions and treatments for presymptomatic AD are currently considered very important. Obesity rates have also been increasing dramatically and it is an independent risk factor of AD. Therefore, for the prevention of AD, it is important to elucidate the pathomechanism between obesity and AD. We generated high calorie diet (HCD)-induced obese tauopathy model mice (PS19), which showed hyperleptinemia but limited insulin resistance. HCD enhanced tau pathology and glial activation. Conversely, voluntary exercise with a running wheel normalized the serum leptin concentration without reducing body weight, and restored the pathological changes induced by HCD. Thus, we speculated that persistent hyperleptinemia played an important role in accelerating pathological changes in PS19 mice. Leptin primarily regulates food intake and body weight via leptin receptor b (LepRb). Interestingly, the nuclear staining for p-STAT3, which was activated by LepRb, was decreased in hippocampal neurons in HCD PS19 mice, indicating leptin resistance. Meanwhile, astroglial activation and the astrocytic expression of a short LepR isoform, LepRa, were enhanced in the hippocampus of HCD PS19 mice. Real-time PCR analysis demonstrated that leptin increased mRNA levels for pro-inflammatory cytokines including IL-1ß and TNF-α in primary cultured astrocytes from wild type and LepRb-deficient mice. These observations suggest that persistent hyperleptinemia caused by obesity induces astrocytic activation, astrocytic leptin hypersensitivity with enhanced LepRa expression, and enhanced inflammation, consequently accelerating tau pathology in PS19 mice.


Assuntos
Astrócitos/metabolismo , Terapia por Exercício/métodos , Hiperlactatemia/etiologia , Obesidade/fisiopatologia , Receptores para Leptina/metabolismo , Tauopatias , Fatores Etários , Animais , Peso Corporal , Células Cultivadas , Córtex Cerebral/citologia , Dieta Hiperlipídica/efeitos adversos , Modelos Animais de Doenças , Ensaio de Imunoadsorção Enzimática , Humanos , Leptina/metabolismo , Proteínas de Membrana/metabolismo , Camundongos , Camundongos Transgênicos , Mutação/genética , Proteínas do Tecido Nervoso/metabolismo , Obesidade/etiologia , Fosforilação/genética , RNA Mensageiro , Receptores para Leptina/genética , Fator de Transcrição STAT3/metabolismo , Tauopatias/genética , Tauopatias/patologia , Tauopatias/reabilitação , Proteínas tau/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...